CLA reduces breast cancer cell growth and invasion through ERalpha and PI3K/Akt pathways

Chem Biol Interact. 2010 Jan 5;183(1):187-93. doi: 10.1016/j.cbi.2009.09.022.

Abstract

We previously reported that conjugated linoleic acid (CLA), a naturally occurring fatty acid, inhibits the growth of ERalpha(+) MCF-7 and ERalpha(-) MDA-MB-231 human breast cancer cells by negative modulation of the ERK/MAPK pathway and apoptosis induction. Here we show that in these cell lines CLA also down-regulates the PI3K/Akt cascade. In MCF-7 cells CLA also triggers ERalpha/PP2A complex formation reducing the phosphorylation state and transcriptional activity of Eralpha whereas in MDA-MB-231 cells CLA does not induce PP2A activation. Moreover, CLA induces the expression of proteins involved in cell adhesion and inhibits cell migration and MMP-2 activity. These findings suggest that CLA may induce the down-regulation of ERalpha signalling and the reduction of cell invasion through the modulation of balancing between phosphatases and kinases.

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Apoptosis
  • Breast Neoplasms / enzymology
  • Breast Neoplasms / metabolism*
  • Cell Adhesion
  • Cell Line, Tumor
  • Cell Movement
  • Down-Regulation
  • Estrogen Receptor alpha / metabolism*
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Female
  • Humans
  • Linoleic Acids, Conjugated / pharmacology*
  • Matrix Metalloproteinase 2 / metabolism
  • Neoplasm Invasiveness
  • Phosphatidylinositol 3-Kinases / metabolism*
  • Protein Phosphatase 2 / metabolism
  • Proto-Oncogene Proteins c-akt / metabolism*
  • Signal Transduction

Substances

  • Antineoplastic Agents
  • Estrogen Receptor alpha
  • Linoleic Acids, Conjugated
  • Phosphatidylinositol 3-Kinases
  • Proto-Oncogene Proteins c-akt
  • Extracellular Signal-Regulated MAP Kinases
  • Protein Phosphatase 2
  • Matrix Metalloproteinase 2